Cited by 57Cervical Cancer and HPV ResearchVaccine Coverage and HesitancyWomen's cancer prevention and management

Access and attitudes to HPV vaccination amongst hard-to-reach populations in Kenya

Open access
Watson-Jones, Deborah, Mugo, Nelly, Lees, Shelley, Mathai, Muthoni, Vusha, Sophie, Ndirangu, Gathari, Ross, David A.·2015·PLOS ONE

Abstract

BACKGROUND: Sub-Saharan Africa bears the greatest burden of cervical cancer. Human papillomavirus (HPV) vaccination programmes to prevent the disease will need to reach vulnerable girls who may not be able access health and screening services in the future. We conducted formative research on facilitators and barriers to HPV vaccination and potential acceptability of a future HPV vaccination programme amongst girls living in hard-to-reach populations in Kenya. METHODS: Stakeholder interviews with Ministry of Health staff explored barriers to and support for the uptake of HPV vaccination. A situation assessment was conducted to assess community services in Maasai nomadic pastoralist communities in Kajiado County and in Korogocho informal settlement in Nairobi city, followed by focus group discussions (n=14) and semi-structured interviews (n=28) with health workers, parents, youth, and community and religious leaders. These covered marriage, knowledge of cervical cancer and HPV, factors that might inhibit or support HPV vaccine uptake and intention to accept HPV vaccine if a programme was in place. RESULTS: Reported challenges to an HPV vaccination programme included school absenteeism and drop-out, early age of sex and marriage, lack of parental support, population mobility and distance from services. Despite little prior knowledge of cervical cancer and HPV, communities were interested in receiving HPV vaccination. Adequate social mobilisation and school-based vaccination, supplemented by out-reach activities, were considered important facilitating factors to achieve high coverage. There was some support for a campaign approach to vaccine delivery. CONCLUSIONS: Given the high level of support for a vaccine against cervical cancer and the experience of reaching pastoralist and slum-dwellers for other immunizations, implementing an HPV vaccine programme should be feasible in such hard-to-reach communities. This may require additional delivery strategies in addition to the standard school-based delivery, with vaccine offered at multiple venues, potentially through a campaign approach.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0123701

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Kenya and Uganda deployed mobile vaccination camps to reach remote and rural populations, ensuring greater coverage among out-of-school adolescents.

    “In Kenya and Uganda, mobile vaccination camps have been deployed to reach remote and rural populations, ensuring greater coverage among out-of-school adolescents58,59.”

    From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [59]

    The Results (Context for providing HPV vaccines) report that Kenya used mobile clinics for a tetanus vaccination programme. The Discussion recommends considering mobile outreach to reach out-of-school girls in a future HPV programme. The paper does not report that Kenya or Uganda deployed mobile HPV vaccination camps or that such camps increased coverage among out-of-school adolescents. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 21

  1. [2]LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S, et al (2011) Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 2011; 89: 821– 830B 22084528 PMC3209730
  2. [3]Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, et al (2012) Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis 206: 678– 686. 10.1093/infdis/jis407 22711908 PMC3414230 · DOI
  3. [4]Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F (2012) Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 90: 623– 628. 10.2471/BLT.11.097253 22893746 PMC3417784 · DOI
  4. [6]Sarode VM (2013) Low Immunization among Children in Slums in Mumbai Middle East Journal of Family Medicine 8: 9– 18. Available: http://www.mejfm.com/Newarchives2013/MEJFM_Vol2018_Iss2012.pdf
  5. [7]Uddin MJ, Larson CP, Oliveras E, Khan AI, Quaiyum MA, Saha NC (2010) Child immunization coverage in urban slums of Bangladesh: impact of an intervention package. Health Policy Plan 25: 50– 60. 10.1093/heapol/czp041 19749011 · DOI
  6. [8]Mutua MK, Kimani-Murage E, Ettarh RR (2011) Childhood vaccination in informal urban settlements in Nairobi, Kenya: who gets vaccinated? BMC Public Health 11: 6 10.1186/1471-2458-11-6 21205306 PMC3024932 · DOI
  7. [9]Kruger C, Olsen OE, Mighay E, Ali M (2013) Immunisation coverage and its associations in rural Tanzanian infants. Rural Remote Health 13: 2457 24215438
  8. [10]Vallely A, Shagi C, Kasindi S, Desmond N, Lees S, Chiduo B, et al (2007) The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania. BMC Public Health 7: 133 17697333 PMC1925085
  9. [11]Marston M, Beguy D, Kabiru C, Cleland J (2013) Predictors of sexual debut among young adolescents in Nairobi's informal settlements. Int Perspect Sex Reprod Health 39: 22– 31. 10.1363/3902213 23584465 PMC4101799 · DOI · Paper page
  10. [12]Unger A (2013) Children's health in slum settings. Arch Dis Child 98: 799– 805. 10.1136/archdischild-2011-301621 23899920 · DOI
  11. [13]Montavon A, Jean-Richard V, Bechir M, Daugla DM, Abdoulaye M, Bongo Nare RN, et al (2013) Health of mobile pastoralists in the Sahel—assessment of 15 years of research and development. Trop Med Int Health 18: 1044– 1052. 10.1111/tmi.12147 23834073 · DOI
  12. [14]Duba HH, Mur-Veeman IM, van Raak A (2001) Pastoralist health care in Kenya. Int J Integr Care 1: e13 16896413 PMC1532930
  13. [15]Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG (2014) Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS ONE 9: e90912 10.1371/journal.pone.0090912 24618636 PMC3949716 · DOI
  14. [16]Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, Soogun S, et al (2011) A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine 29: 8760– 8765. 10.1016/j.vaccine.2011.07.116 21855591 · DOI
  15. [17]Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS (2010) HPV vaccine acceptability among Kenyan women. Vaccine 28: 4864– 4867. 10.1016/j.vaccine.2010.05.034 20566394 PMC2906622 · DOI
  16. [18]Coleman MA, Levison J, Sangi-Haghpeykar H (2011) HPV vaccine acceptability in Ghana, West Africa. Vaccine 29: 3945– 3950. 10.1016/j.vaccine.2011.03.093 21481327 · DOI
  17. [19]Remes P, Selestine V, Changalucha J, Ross DA, Wight D, de Sanjose S, et al (2012) A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine 30: 5363– 5367. 10.1016/j.vaccine.2012.06.025 22732428 PMC3409375 · DOI
  18. [20]Nghi NQ, Lamontagne DS, Bingham A, Rafiq M, Mai le TP, Lien NT, et al (2010) Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health 7: 262– 270. 10.1071/SH09123 20719213 · DOI
  19. [21]Katahoire RA, Jitta J, Kivumbi G, Murokora D, Arube WJ, Siu G, et al (2008) An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health 12: 159– 172. 19435020
  20. [22]Watson-Jones D, Tomlin K, Remes P, Baisley K, Ponsiano R, Soteli S, et al (2012) Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS ONE 7: e45231 10.1371/journal.pone.0045231 23115621 PMC3480345 · DOI
  21. [24]Cummings MJ, Wamala JF, Komakech I, Malimbo M, Lukwago L (2014) Emerging and reemerging epidemic-prone diseases among settling nomadic pastoralists in Uganda. Acta Trop 137: 19– 24. 10.1016/j.actatropica.2014.04.025 24784434 · DOI

Cited by

Sorted by citations

Authors
Watson-Jones, D., Mugo, N., Lees, S., Mathai, M., Vusha, S., Ndirangu, G., & Ross, D. A.
Affiliations
  • Kenya Medical Research Institute (KE)
  • London School of Hygiene & Tropical Medicine (GB)
  • University of Nairobi (KE)
  • Ministry of Health (KE)
Venue
PLOS ONE
Published
2015-06-26
Volume
10
Issue
6
Pages
e0123701
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1487099310
Cited by
57
References
0
Citations by year
2026: 7 · 2025: 11 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 8 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 1 · 2015: 1
FWCI
3.14
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Nairobi Research Archive (University of Nairobi) (submittedVersion)
  • Greater South Information System
Funders
World Health Organization
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords
HPV vaccination, cervical cancer prevention, hard-to-reach populations, barriers to vaccination, vaccine acceptance, Maasai pastoralists, informal settlements, school absenteeism, early marriage, parental support, social mobilization, school-based vaccination, vaccine delivery strategies, Kenya
MeSH terms
Adolescent, Uterine Cervical Neoplasms, Child, Female, Health Services Accessibility, Humans, Kenya, Health Knowledge, Attitudes, Practice, Patient Acceptance of Health Care, Sexual Behavior, Vaccination, Focus Groups, Papillomavirus Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review